Safety and effectiveness of albuterol administered with or without a spacer device in children < 4 years of age has not been demonstrated 3 randomized, double-blind, placebo-controlled studies in 250 children < 4 years, in which efficacy was not demonstrated, suggest that either the optimal dose has not been defined in this age-group or the drug is not effective in this age-group Information on clinical studies
|